Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Exploring heterogeneity in survival benefit of neoadjuvant therapy for triple-negative breast cancer using causal survival forests.

INTRODUCTION The individual survival benefit of neoadjuvant therapy (NAT) for patients with triple-negative breast cancer (TNBC) remains uncertain. This study aimed to evaluate the individualized treatment effect (ITE) of NAT on event-free survival (EFS) in patients with TNBC using causal survival forests. METHODS Th...

Wenjai Xu, Yan-Peng Wu, Yong-Li Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.